The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Dynavax Announces $100 Million Accelerated Share Repurchase Program
Nov 11, 2024•over 1 year ago
Contract Type
agreement
EmeryvilleBiotechnologyBiopharma
Description
Dynavax Technologies Corporation has entered into an Accelerated Share Repurchase transaction under an agreement with Goldman Sachs & Co. LLC to repurchase $100 million of the Company's common stock. The ASR is part of the $200 million share repurchase program authorized by its Board of Directors in November 2024. Upon completion of this ASR, Dynavax will have $100 million remaining under the program
Company Information
Company
Dynavax Technologies
Location
Emeryville, California, United States
About
Dynavax Technologies Corp. is a biopharmaceutical company that focuses on developing and commercializing novel vaccines.
EmeryvilleBiotechnologyBiopharma